Obesity is associated with multiple chronic conditions, and the clustering of obesity‑related diseases can produce substantial long‑term healthcare costs. This study examined racial differences in the lifetime economic burden of obesity‑related multimorbidity (ORM) for U.S. adults older than 40 years. The authors aimed to quantify two outcomes: lifetime healthcare costs (LHCs) and the lifetime healthcare cost differential (LCD) attributable to ORM when comparing persons with ORM to those without obesity‑related diseases (ORDs).
The analysis used the 2008–2012 Medical Expenditure Panel Survey (MEPS) Household Component as the empirical data source. The study identified unique obesity‑related diseases as: high blood sugar, hypertension, coronary heart disease, and stroke. To estimate lifetime costs from age >40 years, the investigators applied a previously published Markov model to simulate an individual’s life history of these ORDs and to compute expected LHCs.
The study computed the LCD associated with ORM as the difference between the LHC for persons with ORM and the LHC for persons without ORDs. Racial differences were quantified as the difference in LHC or LCD between White and Black men and women.
The analytic sample included 53,035 Black and White persons in the MEPS data. When weighted, this sample represented 97,229,611 individuals (standard error 2,104,365). In the weighted population, 12.4% were Black and 87.6% were White. ORM prevalence differed by race: 21.2% among Black respondents versus 13.4% among White respondents.
The paper reports age‑ and sex‑specific LHCs and LCDs (in 2012 USD) for four age bands: 40–49, 50–59, 60–69, and 70–79. The source indicates that LHCs and LCDs vary across race, sex, and age groups and that ORM was generally more prevalent and economically burdensome in the Black group. The source text presents numerical estimates for LHCs and LCDs but contains inconsistent formatting for several reported figures (for example, values reported for some age/sex/race strata include spacing and punctuation irregularities). Because these numeric entries are reported with formatting issues in the source, the precise point estimates cannot be unambiguously restated here without risk of transcription error.
Despite formatting inconsistencies in the reported table of values, the authors emphasize two consistent patterns: first, ORM prevalence and associated lifetime costs are higher in the Black population overall; second, the magnitude and direction of LHCs and LCDs differ by age band and by sex, such that some subpopulations show larger lifetime cost burdens while others show smaller or even negative differentials in the source report.
The analysis indicates persistent racial differences in the lifetime healthcare economic burden associated with ORM among adults aged >40 years. Higher ORM prevalence among Black adults translates into greater lifetime costs for many subgroups in this study. The authors highlight the need for interventions to prevent and manage ORM that prioritize populations with high LHCs in order to advance health equity. Targeted prevention, earlier management of ORDs, and policies addressing upstream determinants of obesity and cardiometabolic disease are implied as relevant strategies, consistent with the authors’ call to prioritize high‑cost populations.
This work uses MEPS 2008–2012 survey data and a previously published Markov model to project lifetime costs; as such, projections depend on the assumptions and parameters of that model and the MEPS sampling and measurement. The article is a medRxiv preprint and has not undergone peer review; the authors explicitly state it should not be used to guide clinical practice. The source notes that all data produced in the work are contained in the manuscript and points readers to MEPS (https://meps.ahrq.gov/mepsweb/) for underlying data. The authors declare no competing interests and report ethical oversight consistent with MEPS data use.
The source included age‑ and sex‑stratified LHC and LCD point estimates but several of those numeric values in the posted preprint were formatted inconsistently; where the source presentation is unclear, exact numeric transcription is not provided here to avoid introducing errors.
Using MEPS data and a Markov modelling approach, the study documents racial differences in lifetime healthcare costs and cost differentials associated with obesity‑related multimorbidity among U.S. adults older than 40. ORM prevalence was higher among Black adults, and LHCs and LCDs varied across age and sex strata. The authors conclude that interventions to prevent and better manage ORM are important for prioritizing high‑cost populations and for advancing health equity. The study was funded by several agencies including the NIH, National Institute on Aging, AHRQ, and Barnes‑Jewish Hospital. Readers should note the preprint status and formatting issues in some reported numeric results in the source document.